LGND - Ligand Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 6 analysts with an average price target of $122.66. This is a potential upside of $18.39 (17.64%) from yesterday's end of day stock price of $104.27.

Ligand Pharmaceuticals's activity chart (see below) currently has 122 price targets and 106 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.61% with an average time for these price targets to be met of 263.75 days.

Highest price target for LGND is $160, Lowest price target is $135, average price target is $145.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 23-Dec-2024. First documented stock forecast 12-Feb-2014.

Currently out of the existing stock ratings of LGND, 31 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$135

$30.73 (29.47%)

$135

3 months 21 days ago
(23-Dec-2024)

7/9 (77.78%)

$21.2 (18.63%)

211

Buy

$160

$55.73 (53.45%)

$150

3 months 28 days ago
(16-Dec-2024)

13/15 (86.67%)

$37.66 (30.78%)

549

Buy

$157

4 months 2 days ago
(11-Dec-2024)

22/40 (55%)

$35.75 (29.48%)

461

Buy

$143

$38.73 (37.14%)

$140

4 months 2 days ago
(11-Dec-2024)

0/5 (0%)

$22.64 (18.81%)

Buy

$147

$42.73 (40.98%)

$135

5 months 5 days ago
(08-Nov-2024)

0/2 (0%)

$25.75 (21.24%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?

On average it took 263.75 days on average for the stock forecasts to be realized with a an average price target met ratio 69.61

Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?

Balaji Prasad with highest potential upside - $55.73

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?

Esther Rajavelu with lowest potential downside - -$38.77

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?